The Mammalian Ovary from Genesis to Revelation

被引:562
作者
Edson, Mark A. [1 ,2 ]
Nagaraja, Ankur K. [1 ,3 ]
Matzuk, Martin M. [1 ,2 ,3 ]
机构
[1] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
FOLLICLE-STIMULATING-HORMONE; PRIMORDIAL GERM-CELLS; SURFACE EPITHELIAL-CELLS; GROWTH-DIFFERENTIATION FACTOR-9; METAPHASE-I-ARREST; BONE MORPHOGENETIC PROTEIN-15; ANTI-MULLERIAN HORMONE; OOCYTE MEIOTIC MATURATION; TUMOR-SUPPRESSOR GENE; FEMALE SEX REVERSAL;
D O I
10.1210/er.2009-0012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two major functions of the mammalian ovary are the production of germ cells (oocytes), which allow continuation of the species, and the generation of bioactive molecules, primarily steroids (mainly estrogens and progestins) and peptide growth factors, which are critical for ovarian function, regulation of the hypothalamic-pituitary-ovarian axis, and development of secondary sex characteristics. The female germline is created during embryogenesis when the precursors of primordial germ cells differentiate from somatic lineages of the embryo and take a unique route to reach the urogenital ridge. This undifferentiated gonad will differentiate along a female pathway, and the newly formed oocytes will proliferate and subsequently enter meiosis. At this point, the oocyte has two alternative fates: die, a common destiny of millions of oocytes, or be fertilized, a fate of at most approximately 100 oocytes, depending on the species. At every step from germline development and ovary formation to oogenesis and ovarian development and differentiation, there are coordinated interactions of hundreds of proteins and small RNAs. These studies have helped reproductive biologists to understand not only the normal functioning of the ovary but also the pathophysiology and genetics of diseases such as infertility and ovarian cancer. Over the last two decades, parallel progress has been made in the assisted reproductive technology clinic including better hormonal preparations, prenatal genetic testing, and optimal oocyte and embryo analysis and cryopreservation. Clearly, we have learned much about the mammalian ovary and manipulating its most important cargo, the oocyte, since the birth of Louise Brown over 30 yr ago. (Endocrine Reviews 30: 624-712, 2009)
引用
收藏
页码:624 / 712
页数:89
相关论文
共 830 条
  • [1] The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction
    Abel, MH
    Wootton, AN
    Wilkins, V
    Huhtaniemi, I
    Knight, PG
    Charlton, HM
    [J]. ENDOCRINOLOGY, 2000, 141 (05) : 1795 - 1803
  • [2] FoxOs at the crossroads of cellular metabolism, differentiation, and transformation
    Accili, D
    Arden, KC
    [J]. CELL, 2004, 117 (04) : 421 - 426
  • [3] A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans
    Achermann, JC
    Ito, M
    Ito, M
    Hindmarsh, PC
    Jameson, JL
    [J]. NATURE GENETICS, 1999, 22 (02) : 125 - 126
  • [4] Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner
    Achermann, JC
    Ozisik, G
    Ito, M
    Orun, UA
    Harmanci, K
    Gurakan, B
    Jameson, JL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) : 1829 - 1833
  • [5] Intercellular communication via connexin43 gap junctions is required for ovarian folliculogenesis in the mouse
    Ackert, CL
    Gittens, JEI
    O'Brien, MJ
    Eppig, JJ
    Kidder, GM
    [J]. DEVELOPMENTAL BIOLOGY, 2001, 233 (02) : 258 - 270
  • [6] ADAMS AT, 1981, CANCER RES, V41, P2063
  • [7] MUTATION IN THE FOLLICLE-STIMULATING-HORMONE RECEPTOR GENE CAUSES HEREDITARY HYPERGONADOTROPIC OVARIAN FAILURE
    AITTOMAKI, K
    LUCENA, JLD
    PAKARINEN, P
    SISTONEN, P
    TAPANAINEN, J
    GROMOLL, J
    KASKIKARI, R
    SANKILA, EM
    LEHVASLAIHO, H
    ENGEL, AR
    NIESCHLAG, E
    HUHTANIEMI, I
    DELACHAPELLE, A
    [J]. CELL, 1995, 82 (06) : 959 - 968
  • [8] Ala-Fossi SL, 2000, EUR J GYNAECOL ONCOL, V21, P187
  • [9] Alfonso-De Matte MY, 2002, CANCER RES, V62, P4575
  • [10] Intracytoplasinic sperm injection (ICSI) - What are the risks?
    Alukal, Joseph P.
    Lamb, Dolores J.
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2008, 35 (02) : 277 - +